Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Mar 13, 2015 424B5
424B2 Mar 12, 2015 424B2
10-K/A Mar 10, 2015 10-K/A
10-K Mar 5, 2015 10-K
8-K Mar 5, 2015 8-K
5 Feb 13, 2015 PRIMARY DOCUMENT
8-K Feb 9, 2015 8-K
SC 13G/A Jan 30, 2015
4 Jan 20, 2015 PRIMARY DOCUMENT
4 Jan 20, 2015 PRIMARY DOCUMENT
4 Jan 20, 2015 PRIMARY DOCUMENT
8-K Jan 14, 2015 8-K
8-K Dec 1, 2014 8-K
424B5 Nov 21, 2014 425B5
EFFECT Nov 20, 2014
424B5 Nov 20, 2014 424B5
8-K Nov 20, 2014 8-K
CORRESP Nov 19, 2014
8-K Nov 7, 2014 8-K
10-Q Nov 5, 2014 10-Q
8-K Nov 3, 2014 8-K
CORRESP Oct 31, 2014
S-3/A Oct 31, 2014 S-3/A
UPLOAD Oct 31, 2014
S-3 Oct 22, 2014 S-3
← Newer Page 30 of 51 · 1272 filings Older →